CN106279123B - 3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method - Google Patents
3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method Download PDFInfo
- Publication number
- CN106279123B CN106279123B CN201610666039.6A CN201610666039A CN106279123B CN 106279123 B CN106279123 B CN 106279123B CN 201610666039 A CN201610666039 A CN 201610666039A CN 106279123 B CN106279123 B CN 106279123B
- Authority
- CN
- China
- Prior art keywords
- imidazoheterocycles
- benzenesulfonylmethyl
- class compound
- class
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CCCCCCl*[C@](CC)[C@@](C)[C@](C[C@](C)N=*)*C(C)=I Chemical compound CCCCCCl*[C@](CC)[C@@](C)[C@](C[C@](C)N=*)*C(C)=I 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于有机化合物合成及应用技术领域,具体涉及一种3-(苯磺酰甲基)咪唑并杂环类化合物的制备方法。The invention belongs to the technical field of synthesis and application of organic compounds, and in particular relates to a preparation method of 3-(benzenesulfonylmethyl) imidazoheterocyclic compounds.
背景技术Background technique
吡啶并咪唑是一类非常重要而且常见的氮杂环化合物(ComprehensiveHeterocyclic Chemistry III)。其衍生物具有很好的生物活性:例如,抗病毒、抗溃疡和抗菌性(J. Med. Chem. 2015, 58, 8529; Bioorg. Med. Chem. Lett. 2013, 23, 4996;J. Med. Chem. 2015, 58, 9238; Bioorg. Med. Chem. 2011, 19, 4227; ACS Med.Chem. Lett. 2013, 4, 675; J. Med. Chem. 1999, 42, 50)。其中有几类药物已经成功的上市,比如抗焦虑药物Alpidem(阿吡坦), Saripidem(沙立吡旦),麻醉药Necopidem(奈可吡旦)和镇静催眠药Zolpidem(唑吡坦)等(J. Med. Chem. 2008, 51, 7243; Exp.Ther. 2001, 299, 793; J. Behav. Pharmacol. 1995, 6, 116)。目前有关吡啶并咪唑化合物及咪唑并杂环类化合物的官能团化反应的研究日趋完善,但关于其磺酰甲基化反应的研究却未见报道。Pyridoimidazole is a very important and common nitrogen heterocyclic compound (ComprehensiveHeterocyclic Chemistry III). Its derivatives have good biological activity: for example, antiviral, antiulcer and antibacterial properties (J. Med. Chem. 2015, 58, 8529; Bioorg. Med. Chem. Lett. 2013, 23, 4996; J. Med. 2015, 58, 9238; Bioorg. Med. Chem. 2011, 19, 4227; ACS Med. Chem. Lett. 2013, 4, 675; J. Med. Chem. 1999, 42, 50). Among them, several types of drugs have been successfully marketed, such as anti-anxiety drugs Alpidem (Alpidem), Saripidem (Saripidem), anesthetic drugs Necopidem (Necopidem) and sedative hypnotics Zolpidem (Zolpidem), etc. ( J. Med. Chem. 2008, 51, 7243; Exp. Ther. 2001, 299, 793; J. Behav. Pharmacol. 1995, 6, 116). At present, the research on the functionalization reaction of pyridoimidazole compounds and imidazoheterocyclic compounds is becoming more and more perfect, but there is no report on the research on the sulfonylmethylation reaction.
对甲苯磺酰甲基异腈在有机合成中应用非常广泛,利用其高活性以及磺酰基团的易离去性(Angew. Chem., Int. Ed. 2010, 49, 9094, Chem. Rev. 2010, 110, 5235,Chem. Rev. 2015, 115, 2698),合成了一系列的杂环化合物,例如吡咯、噁唑、咪唑等氮杂环化合物(Chem. Commun. 2014, 50, 11837, Chem. Eur. J. 2015, 21, 18949, Org.Lett. 2014, 16, 4004, Adv. Synth. Catal. 2014, 356, 2974)。此反应实现了对甲苯磺酰甲基异腈的另一种反应方式,利用简单的反应体系实现了磺酰甲基化反应。p-Toluenesulfonylmethyl isonitrile is widely used in organic synthesis, taking advantage of its high activity and the ease of leaving the sulfonyl group (Angew. Chem., Int. Ed. 2010, 49, 9094, Chem. Rev. 2010 , 110, 5235,Chem. Rev. 2015, 115, 2698), synthesized a series of heterocyclic compounds, such as pyrrole, oxazole, imidazole and other nitrogen heterocyclic compounds (Chem. Commun. 2014, 50, 11837, Chem. Eur. J. 2015, 21, 18949, Org. Lett. 2014, 16, 4004, Adv. Synth. Catal. 2014, 356, 2974). This reaction realizes another reaction mode of p-toluenesulfonylmethylisonitrile, and realizes the sulfonylmethylation reaction with a simple reaction system.
发明内容Contents of the invention
本发明的目的是提供一种3-(苯磺酰甲基)咪唑并杂环类化合物的合成及制备方法,该方法简单易行,成本低廉且易于纯化。The object of the present invention is to provide a kind of synthetic and preparation method of 3-(benzenesulfonylmethyl) imidazoheterocyclic compound, and this method is simple and easy, with low cost and easy to purify.
为实现上述目的,本发明采用以下技术方案:To achieve the above object, the present invention adopts the following technical solutions:
一种3-(苯磺酰甲基)咪唑并杂环类化合物,其结构通式为:A 3-(benzenesulfonylmethyl) imidazoheterocyclic compound, its general structural formula is:
其中X=C、O或S;n=0或1;R1为氢、烷基、烷氧基或卤素;Het为噻唑类、噻唑啉类、苯并噻唑类、喹啉类或噁唑类杂环基。where X=C, O or S; n=0 or 1 ; R1 is hydrogen, alkyl, alkoxy or halogen; Het is thiazole, thiazoline, benzothiazole, quinoline or oxazole heterocyclyl.
所述的3-(苯磺酰甲基)咪唑并杂环类化合物的制备方法,包括下述步骤:在氩气环境下,将咪唑并杂环类化合物与苯磺酰甲基异腈类衍生物加入反应管中,加入三氯化铁,然后加入绿色溶剂,80~120℃下反应18~48小时;反应结束后萃取、色谱分离、干燥既得目标产物,反应方程式如下:The preparation method of the described 3-(benzenesulfonylmethyl) imidazoheterocyclic compound comprises the following steps: under an argon atmosphere, derivatizing the imidazoheterocyclic compound with benzenesulfonylmethyl isocyanide Put the material into the reaction tube, add ferric chloride, then add green solvent, and react at 80~120°C for 18~48 hours; after the reaction is completed, extract, chromatographically separate, and dry to obtain the target product. The reaction equation is as follows:
; ;
所述咪唑并杂环类化合物的通式为:The general formula of the imidazoheterocyclic compound is:
苯磺酰甲基异腈类衍生物的结构通式为:The general structural formula of benzenesulfonylmethyl isonitrile derivatives is:
其中X=C、O或S;n=0、1;R1为氢、烷基、烷氧基或卤素;Het为噻唑类、噻唑啉类、苯并噻唑类、喹啉类或噁唑类杂环基。Where X = C, O or S; n = 0, 1; R 1 is hydrogen, alkyl, alkoxy or halogen; Het is thiazoles, thiazolines, benzothiazoles, quinolines or oxazoles heterocyclyl.
所述咪唑并杂环类化合物与苯磺酰甲基异腈类衍生物的物质的量比为1:2或1:3。The molar ratio of the imidazoheterocyclic compound to the benzenesulfonylmethylisonitrile derivative is 1:2 or 1:3.
所述三氯化铁的用量为咪唑并杂环类化合物的物质的量的0.1~0.3倍。The amount of the ferric chloride is 0.1-0.3 times of the amount of imidazo heterocyclic compounds.
所述的绿色溶剂为水和聚乙二醇400按体积比0~10:10~0混合制成,以0.1mmol咪唑并杂环类化合物的物质的量为基准,所述绿色溶剂的用量为2mL。The green solvent is made by mixing water and polyethylene glycol 400 in a volume ratio of 0~10:10~0, based on the amount of 0.1mmol imidazoheterocyclic compound, the amount of the green solvent is 2mL.
所述萃取采用的萃取剂为二氯甲烷。The extractant used in the extraction is dichloromethane.
所述色谱分离采用的洗脱剂为体积比为0~100:100~0的乙酸乙酯和石油醚。The eluent used in the chromatographic separation is ethyl acetate and petroleum ether in a volume ratio of 0-100:100-0.
本发明的有益效果:本发明为合成咪唑并杂环类化合物提供了一种简便易行的方法。该反应利用廉价金属铁(Ⅲ)作为催化剂,绿色无毒的水和聚乙二醇400作为反应溶剂,实现了咪唑并杂环类化合物与苯磺酰甲基异腈类衍生物的磺酰甲基化反应,所得化合物的磺酰基可以作为离去基团,实现进一步的官能团化反应,这将为该方法的应用提供更多的可行性途径。该方法简单高效,成本低廉且易于纯化,丰富了咪唑并杂环类化合物的的官能团化反应类型,同时也实现苯磺酰甲基异腈类衍生物的新的反应方式。该方法将对咪唑并杂环类化合物的磺酰甲基化反应的研究和应用具有重要意义。Beneficial effects of the present invention: the present invention provides a simple and easy method for synthesizing imidazoheterocyclic compounds. The reaction uses cheap metal iron (Ⅲ) as a catalyst, green non-toxic water and polyethylene glycol 400 as a reaction solvent, and realizes the sulfonylformation of imidazoheterocyclic compounds and benzenesulfonylmethylisonitrile derivatives. The sulfonyl group of the obtained compound can be used as a leaving group to realize further functionalization reaction, which will provide more feasible ways for the application of this method. The method is simple and efficient, has low cost and is easy to purify, enriches the functional group reaction types of imidazoheterocyclic compounds, and also realizes a new reaction mode of benzenesulfonylmethylisonitrile derivatives. This method will be of great significance to the research and application of the sulfonylmethylation reaction of imidazoheterocyclic compounds.
具体实施方式Detailed ways
下面结合具体实施例,对本发明做进一步说明。应理解,以下实施例仅用于说明本发明而非用于限制本发明的范围,该领域的技术熟练人员可以根据上述发明的内容作出一些非本质的改进和调整。The present invention will be further described below in conjunction with specific embodiments. It should be understood that the following examples are only used to illustrate the present invention rather than limit the scope of the present invention, and those skilled in the art can make some non-essential improvements and adjustments based on the content of the above invention.
实施例1Example 1
本实施例的化合物2-(呋喃-2-基)-3-(甲苯磺酰甲基)咪唑并[1,2-a]吡啶的结构为:The structure of the compound 2-(furan-2-yl)-3-(tosylmethyl)imidazo[1,2- α ]pyridine of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的2-呋喃基咪唑并[1,2-a]吡啶化合物,0.2 mmol的对甲苯磺酰甲基异腈,0.02mmol的三氯化铁,水2 mL,100℃反应36小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率90%。m.p. = 163-164℃. 1H NMR (600 MHz, CDCl3) δ 8.40 (d, J = 6.9 Hz, 1H), 7.60(d, J = 9.1 Hz, 1H), 7.38 (d, J = 8.2 Hz, 2H), 7.32-7.29 (m, 1H), 7.13 (dd, J= 1.6, 0.5 Hz, 1H), 7.06 (d, J = 7.9 Hz, 2H), 6.94 (td, J = 6.8, 1.0 Hz, 1H),6.66 (d, J = 1.1 Hz, 1H), 6.31 (dd, J = 3.4, 1.8 Hz, 1H), 5.08 (s, 2H), 2.27(s, 3H). 13C NMR (150 MHz, CDCl3) δ 149.1, 146.3, 145.1, 142.0, 137.8, 133.9,129.2, 128.4, 126.3, 124.6, 117.3, 112.9, 111.1, 108.4, 108.0, 52.7, 21.5.HRMS (positive ESI): [M+H]+ calcd for C19H17N2O3S+: 353.0954, found 353.0961.Preparation method: Add 0.1 mmol of 2-furylimidazo[1,2-a]pyridine compound, 0.2 mmol of p-toluenesulfonylmethyl isocyanide, 0.02 Mmol of ferric chloride, 2 mL of water, react at 100°C for 36 hours; after the reaction, extract with dichloromethane, concentrate under reduced pressure and then chromatographically separate (silica gel 200-300 mesh), eluent: ethyl acetate/petroleum Gradient elution with ether, the ratio is from 0/100 to 100/0), and drying to obtain a white solid with a yield of 90%. mp = 163-164℃. 1 H NMR (600 MHz, CDCl 3 ) δ 8.40 (d, J = 6.9 Hz, 1H), 7.60(d, J = 9.1 Hz, 1H), 7.38 (d, J = 8.2 Hz , 2H), 7.32-7.29 (m, 1H), 7.13 (dd, J= 1.6, 0.5 Hz, 1H), 7.06 (d, J = 7.9 Hz, 2H), 6.94 (td, J = 6.8, 1.0 Hz, 1H),6.66 (d, J = 1.1 Hz, 1H), 6.31 (dd, J = 3.4, 1.8 Hz, 1H), 5.08 (s, 2H), 2.27(s, 3H). 13 C NMR (150 MHz, CDCl 3 ) δ 149.1, 146.3, 145.1, 142.0, 137.8, 133.9, 129.2, 128.4, 126.3, 124.6, 117.3, 112.9, 111.1, 108.4, 108.0, 52.7, 21.5 . calcd for C 19 H 17 N 2 O 3 S + : 353.0954, found 353.0961.
实施例2Example 2
本实施例的化合物2-(噻吩-2-基)-3-(甲苯磺酰甲基)咪唑并[1,2-a]吡啶的结构为:The structure of the compound 2-(thiophen-2-yl)-3-(tosylmethyl)imidazo[1,2- a ]pyridine of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的2-噻吩基咪唑并[1,2-a]吡啶化合物,0.3 mmol的对甲苯磺酰甲基异腈,0.03mmol的三氯化铁,聚乙二醇400 2mL,100℃反应18小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率87%。m.p. = 161-162℃. 1H NMR (600 MHz, CDCl3) δ 8.33 (d, J = 6.9 Hz, 1H),7.64 (d, J = 9.1 Hz, 1H), 7.50 (d, J = 8.3 Hz, 2H), 7.31-7.26 (m, 2H), 7.15(d, J = 8.0 Hz, 2H), 7.02 (dd, J = 3.6, 1.0 Hz, 1H), 6.95 (dd, J = 5.0, 3.7Hz, 1H), 6.90 (td, J = 6.8, 1.0 Hz, 1H), 4.90 (s, 2H), 2.35 (s, 3H). 13C NMR(150 MHz, CDCl3) δ 146.0, 145.5, 141.7, 135.9, 134.5, 129.9, 128.3, 127.4,126.3, 126.1, 125.2, 124.6, 117.4, 113.0, 107.5, 53.1, 21.6. HRMS (positiveESI): [M+H]+ calcd for C19H17N2O2S2 +: 369.0726, found 369.0730.Preparation method: Add 0.1 mmol of 2-thienylimidazo[1,2-a]pyridine compound, 0.3 mmol of p-toluenesulfonylmethyl isocyanide, 0.03 Mmol of ferric chloride, polyethylene glycol 400 2mL, react at 100°C for 18 hours; after the reaction, extract with dichloromethane, concentrate under reduced pressure and then chromatographically separate (silica gel 200-300 mesh), eluent: ethyl acetate Gradient elution with ester/petroleum ether, the ratio is from 0/100 to 100/0), and dried to obtain a white solid with a yield of 87%. mp = 161-162℃. 1 H NMR (600 MHz, CDCl 3 ) δ 8.33 (d, J = 6.9 Hz, 1H),7.64 (d, J = 9.1 Hz, 1H), 7.50 (d, J = 8.3 Hz , 2H), 7.31-7.26 (m, 2H), 7.15(d, J = 8.0 Hz, 2H), 7.02 (dd, J = 3.6, 1.0 Hz, 1H), 6.95 (dd, J = 5.0, 3.7Hz, 1H), 6.90 (td, J = 6.8, 1.0 Hz, 1H), 4.90 (s, 2H), 2.35 (s, 3H). 13 C NMR(150 MHz, CDCl 3 ) δ 146.0, 145.5, 141.7, 135.9, 134.5, 129.9, 128.3, 127.4, 126.3, 126.1, 125.2, 124.6, 117.4, 113.0, 107.5, 53.1, 21.6. HRMS (positiveESI): [M + H] + calcd for C 19 H 17 N 2 O 2 S : 369.0726, found 369.0730.
实施例3Example 3
本实施例的化合物6-苯基-5-(甲苯磺酰甲基)咪唑并[2,1-b]噻唑的结构式为:The structural formula of the compound 6-phenyl-5-(tosylmethyl)imidazo[2,1- b ]thiazole of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的6-苯基咪唑并[2,1-b]噻唑化合物,0.3mmol的对甲苯磺酰甲基异腈,0.01mmol的三氯化铁,水和聚乙二醇400(体积比7:3)2 mL,120℃反应24小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率85%。 m.p. = 39-40℃. 1H NMR (600 MHz, CDCl3) δ 7.71 (d, J = 4.5Hz, 1H), 7.45 (d, J = 8.2 Hz, 2H), 7.24-7.23 (m, 3H), 7.18-7.14 (m, 4H), 6.90(d, J = 4.5 Hz, 1H), 4.69 (s, 2H), 2.37 (s, 3H). 13C NMR (150 MHz, CDCl3) δ150.9, 148.7, 145.4, 134.1, 133.2, 129.9, 128.29, 128.27, 127.8, 127.6,119.1, 112.6, 109.8, 53.6, 21.6. HRMS (positive ESI): [M+H]+ calcd forC19H17N2O2S2 +: 369.0726, found 369.0732.Preparation method: Add 0.1 mmol of 6-phenylimidazo[2,1- b ]thiazole compound, 0.3 mmol of p-toluenesulfonylmethyl isonitrile, 0.01 Mmol of ferric chloride, water and polyethylene glycol 400 (volume ratio 7:3) 2 mL, react at 120°C for 24 hours; 300 mesh), eluent: ethyl acetate/petroleum ether gradient elution, the ratio is from 0/100 to 100/0), and dried to obtain a white solid with a yield of 85%. mp = 39-40℃. 1 H NMR (600 MHz, CDCl 3 ) δ 7.71 (d, J = 4.5Hz, 1H), 7.45 (d, J = 8.2 Hz, 2H), 7.24-7.23 (m, 3H) , 7.18-7.14 (m, 4H), 6.90(d, J = 4.5 Hz, 1H), 4.69 (s, 2H), 2.37 (s, 3H). 13 C NMR (150 MHz, CDCl 3 ) δ150.9, 148.7, 145.4, 134.1 , 133.2 , 129.9 , 128.29 , 128.27 , 127.8, 127.6, 119.1, 112.6, 109.8, 53.6, 21.6. 2+ : 369.0726 , found 369.0732.
实施例4Example 4
本实施例的化合物6-苯基-5-(对甲苯磺酰基甲基)-2,3-二氢咪唑并[2,1-b]噻唑的结构式为:The structural formula of the compound 6-phenyl-5-(p-toluenesulfonylmethyl)-2,3-dihydroimidazo[2,1- b ]thiazole of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的6-苯基-2,3-二氢咪唑并[2,1-b]噻唑化合物,0.3mmol的对甲苯磺酰甲基异腈,0.03mmol的三氯化铁,水和聚乙二醇400(体积比4:1)2 mL,80℃反应48小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率95%。m.p. = 48-49℃. 1H NMR (600 MHz, CDCl3) δ 7.42(d, J = 8.3 Hz, 2H), 7.18-7.15 (m, 3H), 7.10-7.08 (m, 4H), 4.48 (s, 2H), 4.38(t, J = 7.3 Hz, 2H), 3.86 (t, J = 7.2 Hz, 2H), 2.34 (s, 3H). 13C NMR (150 MHz,CDCl3) δ 151.3, 147.9, 145.3, 133.9, 133.3, 129.8, 128.2, 128.1, 127.2,126.8, 114.0, 53.4, 46.3, 34.8, 21.6. HRMS (positive ESI): [M+H]+ calcd forC19H19N2O2S2 +: 371.0882, found 371.0890.Preparation method: Add 0.1 mmol of 6-phenyl-2,3-dihydroimidazo[2,1- b ]thiazole compound and 0.3 mmol of p-toluenesulfonate to a 10 mL Shrek tube under the protection of argon Acylmethyl isonitrile, 0.03 mmol of ferric chloride, water and polyethylene glycol 400 (volume ratio 4:1) 2 mL, react at 80°C for 48 hours; after the reaction, extract with dichloromethane and concentrate under reduced pressure After chromatographic separation (silica gel 200-300 mesh), eluent: ethyl acetate/petroleum ether gradient elution, the ratio is from 0/100 to 100/0), and dried to obtain a white solid with a yield of 95%. mp = 48-49℃. 1 H NMR (600 MHz, CDCl 3 ) δ 7.42(d, J = 8.3 Hz, 2H), 7.18-7.15 (m, 3H), 7.10-7.08 (m, 4H), 4.48 ( s, 2H), 4.38(t, J = 7.3 Hz, 2H), 3.86 (t, J = 7.2 Hz, 2H), 2.34 (s, 3H). 13 C NMR (150 MHz, CDCl 3 ) δ 151.3, 147.9 , 145.3, 133.9, 133.3, 129.8 , 128.2 , 128.1 , 127.2 , 126.8 , 114.0 , 53.4, 46.3, 34.8, 21.6. + : 371.0882, found 371.0890.
实施例5Example 5
本实施例的化合物2-苯基-3-(对甲苯磺酰基甲基)苯并[d]咪唑并[2,1-b]噻唑的结构式为:The structural formula of the compound 2-phenyl-3-(p-toluenesulfonylmethyl)benzo[ d ]imidazo[2,1- b ]thiazole of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的2-苯基-苯并[d]咪唑并[2,1-b]噻唑化合物,0.3 mmol的对甲苯磺酰甲基异腈,0.03mmol的三氯化铁,水和聚乙二醇400(体积比3:2)2 mL,110℃反应24小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率41%。 m.p. = 179-180℃. 1H NMR (600 MHz, CDCl3) δ8.08 (d, J = 8.3 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.52-7.49 (m, 1H), 7.39(t, J = 7.8 Hz, 1H), 7.34 (d, J = 8.2 Hz, 2H), 7.24-7.22 (m, 5H), 5.08 (s,2H), 2.33 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 149.7, 148.9, 145.2, 134.0,133.1, 132.9, 130.2, 129.6, 128.3, 128.2, 127.7, 126.1, 125.0, 124.2, 114.7,112.1, 52.8, 21.6. HRMS (positive ESI): [M+H]+ calcd for C23H19N2O2S2 +:419.0882, found 419.0889.Preparation method: Add 0.1 mmol of 2-phenyl-benzo[ d ]imidazo[2,1- b ]thiazole compound, 0.3 mmol of p-toluenesulfonyl to a 10 mL Shrek tube under the protection of argon Methyl isonitrile, 0.03 mmol of ferric chloride, water and polyethylene glycol 400 (volume ratio 3:2) 2 mL, react at 110°C for 24 hours; after the reaction, extract with dichloromethane and concentrate under reduced pressure Chromatographic separation (silica gel 200-300 mesh), eluent: ethyl acetate/petroleum ether gradient elution, ratio from 0/100 to 100/0), and drying to obtain a white solid with a yield of 41%. mp = 179-180℃. 1 H NMR (600 MHz, CDCl 3 ) δ8.08 (d, J = 8.3 Hz, 1H), 7.72 (d, J = 8.0 Hz, 1H), 7.52-7.49 (m, 1H ), 7.39(t, J = 7.8 Hz, 1H), 7.34 (d, J = 8.2 Hz, 2H), 7.24-7.22 (m, 5H), 5.08 (s,2H), 2.33 (s, 3H). 13 C NMR (150 MHz, CDCL 3 ) Δ 149.7, 148.9, 145.2, 134.0,133.1, 132.9, 130.2, 129.6, 128.2, 127.7, 125.0, 124.7,112.1, 52.8, HRMS (Positive ESI ): [M+H] + calcd for C 23 H 19 N 2 O 2 S 2 + :419.0882, found 419.0889.
实施例6Example 6
本实施例的化合物2-苯基-1-(甲苯磺酰甲基)咪唑并[1,2-a]喹啉的结构式为:The structural formula of the compound 2-phenyl-1-(tosylmethyl)imidazo[1,2- α ]quinoline of the present embodiment is:
; ;
制备方法:在氩气保护环境下,往10 mL史莱克管中加入0.1 mmol的2-苯基咪唑并[1,2-a]喹啉化合物,0.2 mmol的对甲苯磺酰甲基异腈,0.02mmol的三氯化铁,水和聚乙二醇400(体积比3:2)2 mL,90℃反应24小时;反应结束后,利用二氯甲烷萃取,减压浓缩后色谱分离(硅胶200-300目),洗脱剂:乙酸乙酯/石油醚梯度淋洗,比例由0/100至100/0),干燥得白色固体,产率46%。m.p. = 184-185℃. 1H NMR (600 MHz, CDCl3) δ 8.56 (d, J =8.7 Hz, 1H), 7.83 (d, J = 7.7 Hz, 1H), 7.71 (t, J = 7.9 Hz, 1H), 7.59 (dd, J= 14.5, 9.3 Hz, 2H), 7.52 (t, J = 7.5 Hz, 1H), 7,27 (s, 3H), 7.21-7.19 (m,2H), 7.16 (d, J = 8.1 Hz, 2H), 6.95 (d, J = 8.0 Hz, 2H), 5.43 (s, 2H), 2.34(s, 3H). 13C NMR (150 MHz, CDCl3) δ 148.4, 145.9, 144.9, 134.6, 134.5, 133.1,129.54, 129.49, 128.7, 128.5, 128.4, 128.3, 128.1, 127.9, 125.1, 124.8,117.2, 117.1, 112.3, 54.5, 21.6. HRMS (positive ESI): [M+H]+ calcd forC25H21N2O2S+: 413.1318, found 413.1318.Preparation method: Add 0.1 mmol of 2-phenylimidazo[1,2-a]quinoline compound, 0.2 mmol of p-toluenesulfonylmethyl isocyanide to a 10 mL Shrek tube under the protection of argon, 0.02mmol of ferric chloride, 2 mL of water and polyethylene glycol 400 (volume ratio 3:2), reacted at 90°C for 24 hours; after the reaction, extracted with dichloromethane, concentrated under reduced pressure and separated by chromatography (silica gel 200 -300 mesh), eluent: ethyl acetate/petroleum ether gradient elution, the ratio is from 0/100 to 100/0), and dried to obtain a white solid with a yield of 46%. mp = 184-185℃. 1 H NMR (600 MHz, CDCl 3 ) δ 8.56 (d, J =8.7 Hz, 1H), 7.83 (d, J = 7.7 Hz, 1H), 7.71 (t, J = 7.9 Hz , 1H), 7.59 (dd, J= 14.5, 9.3 Hz, 2H), 7.52 (t, J = 7.5 Hz, 1H), 7,27 (s, 3H), 7.21-7.19 (m,2H), 7.16 ( d, J = 8.1 Hz, 2H), 6.95 (d, J = 8.0 Hz, 2H), 5.43 (s, 2H), 2.34(s, 3H). 13 C NMR (150 MHz, CDCl 3 ) δ 148.4, 145.9 , 144.9, 134.6, 134.5, 133.1,129.54, 129.49, 128.7, 128.5, 128.3, 128.1, 127.9, 124.8,117.2, 117.1, 54.5, HRMS (Positive ESI): [m+h] + calcd for C 25 H 21 N 2 O 2 S + : 413.1318, found 413.1318.
以上显示和描述了本发明的基本原理和主要特征以及本发明的优点。本行业的技术人员应该了解,本发明不受上述实施例的限制,上述实施例和说明书中描述的只是说明本发明的原理,在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,这些变化和改进都落入要求保护的本发明范围内。本发明要求保护范围由所附的权利要求书及其等效物界定。The basic principles and main features of the present invention and the advantages of the present invention have been shown and described above. Those skilled in the industry should understand that the present invention is not limited by the above-mentioned embodiments, and what described in the above-mentioned embodiments and the description only illustrates the principles of the present invention, and the present invention will also have other functions without departing from the spirit and scope of the present invention. Variations and improvements are possible, which fall within the scope of the claimed invention. The protection scope of the present invention is defined by the appended claims and their equivalents.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610666039.6A CN106279123B (en) | 2016-08-15 | 2016-08-15 | 3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610666039.6A CN106279123B (en) | 2016-08-15 | 2016-08-15 | 3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106279123A CN106279123A (en) | 2017-01-04 |
| CN106279123B true CN106279123B (en) | 2018-09-04 |
Family
ID=57670319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610666039.6A Expired - Fee Related CN106279123B (en) | 2016-08-15 | 2016-08-15 | 3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106279123B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108997337A (en) * | 2018-08-10 | 2018-12-14 | 郑州大学 | N- (2- heterocyclic base imidazo heteroaromatic -3- base) dibenzenesulfonimide class compound and its synthetic method |
| CN109810105B (en) * | 2019-02-26 | 2020-07-17 | 郑州大学 | N- ((2-phenylimidazo [1,2-a ] pyridine-3-yl) methyl) aniline compound and synthetic method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0165545A2 (en) * | 1984-06-18 | 1985-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Imidazoisoquinoline compounds and processes for preparation thereof |
| CN102869661A (en) * | 2010-03-18 | 2013-01-09 | 韩国巴斯德研究所 | Anti-infective compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497278B2 (en) * | 2008-05-19 | 2013-07-30 | Sunovion Pharmaceuticals Inc. | Imidazo[1,2-a]pyridine compounds |
| US9394305B2 (en) * | 2014-06-23 | 2016-07-19 | Dr. Reddy's Laboratories Ltd. | Substituted imidazo[1,2-a]pyridine compounds as tropomyosin receptor kinase a (TrkA) inhibitors |
-
2016
- 2016-08-15 CN CN201610666039.6A patent/CN106279123B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0165545A2 (en) * | 1984-06-18 | 1985-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Imidazoisoquinoline compounds and processes for preparation thereof |
| CN102869661A (en) * | 2010-03-18 | 2013-01-09 | 韩国巴斯德研究所 | Anti-infective compounds |
Non-Patent Citations (1)
| Title |
|---|
| Microwave assisted novel and regioselective functionalization of imidazopyridines with chromene acetals and b-nitrostyrenes;L.Chandrasekhara Rao et al.;《RSC Advances》;20150812;第5卷;第70949-70957页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106279123A (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Su et al. | Recent progress in the use of Vilsmeier-type reagents | |
| Monir et al. | Regioselective synthesis of nitrosoimidazoheterocycles using tert-butyl nitrite | |
| Li et al. | Synthesis of disulfides tethered pyrroles from β-ketothioamides via a bicyclization/ring-opening/oxidative coupling reaction | |
| CN106279123B (en) | 3- (benzenesulfonylmethyl) imidazoheterocycles class compound and its synthetic method | |
| Kamalraja et al. | Microwave assisted InCl3 mediated regioselective synthesis of highly functionalized indolylpyran under solvent-free condition and its chemical transformation to indolyltriazolylpyran hybrids | |
| CN106279159B (en) | 2 phenyl 3 (tosyl methyl) imidazo [1,2 a] pyridine compounds and theirs and its synthetic method | |
| CN105524013B (en) | 4,5- bis- substitutes the preparation method of -2- substituted-amino thiazolium compounds | |
| Zhu et al. | One-pot three-component strategy for polysubstituted 2-aminothiazoles via ring opening of α-nitro epoxides | |
| CN111303079A (en) | Method for synthesizing thioamides in aqueous phase of elemental sulfur promoted by mixed alkali | |
| de Souza et al. | An improved protocol for the synthesis of carbonyl sulfoxonium ylides | |
| Bezboruah et al. | KF/Al2O3/PEG-400: an efficient catalytic system for the fiesselmann-type synthesis of thiophene derivatives | |
| CN108689901B (en) | Synthetic method of aziridine compound | |
| CN108997337A (en) | N- (2- heterocyclic base imidazo heteroaromatic -3- base) dibenzenesulfonimide class compound and its synthetic method | |
| Rassukana | Methyl α-iminotrifluoropropionate: a novel convenient building block for the preparation of functionalized derivatives bearing a trifluoroalanine residue | |
| CN109824702B (en) | Bis(2-heteroarylimidazo[1,2-a]pyridin-3-yl)sulfide compounds and synthesis method thereof | |
| CN109776574B (en) | Bis(2-(imidazo[1,2-a]pyridin-2-yl)phenyl)sulfide compounds and synthesis method thereof | |
| CN103232406B (en) | A kind of 1,3-thiazoles derivative | |
| CN106117247A (en) | A kind of preparation method of 2 methyl 1,2,3,9 tetrahydro benzo [b] pyrroles [1,4] thiazine 1,3 cyclohexadione compounds | |
| CN108774248B (en) | Method for preparing thiazoloquinazolinone derivative | |
| CN104592179B (en) | The preparation method of 3-position thiobenzofuran compound | |
| CN104860864B (en) | The synthetic method of the alkynyl azole compounds of 2 carbonyl 5 | |
| Narender | Antimicrobial Activity of 2-Aminothiophene Derivatives | |
| CN104370877B (en) | A kind of 2,5 2 substituted thiophene class compounds and preparation method thereof | |
| Kálai et al. | Synthesis of new paramagnetic selenophenes | |
| Ichikawa et al. | Mutagenicity of 3, 4-diphenyl-5-nitrofuran analogs in Salmonella typhimurium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20180904 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |